tiprankstipranks
Advertisement
Advertisement

DE:BM8 Stock Latest News

BioMarin’s Voxzogo and BMN 333 show impact in hypochondroplasia, achondroplasia
The FlyBioMarin’s Voxzogo and BMN 333 show impact in hypochondroplasia, achondroplasia
11d ago
BMRN
Ascendis Pharma ‘oversold’ following ITC development, says Oppenheimer
PremiumThe Fly
Ascendis Pharma ‘oversold’ following ITC development, says Oppenheimer
19d ago
ASND
BMRN
BioMarin Shareholders Approve 2026 Governance and Equity Plan
PremiumCompany Announcements
BioMarin Shareholders Approve 2026 Governance and Equity Plan
23d ago
8K
BMRN
Jason Gerberry Maintains Buy on BioMarin, Reiterates $80 Price Target Despite Voxzogo Patent Uncertainty
PremiumRatings
Jason Gerberry Maintains Buy on BioMarin, Reiterates $80 Price Target Despite Voxzogo Patent Uncertainty
27d ago
BMRN
BioMarin price target lowered to $111 from $116 at Canaccord
PremiumThe Fly
BioMarin price target lowered to $111 from $116 at Canaccord
1M ago
BMRN
Buy Rating Reaffirmed on BioMarin as Voxzogo Skeletal Disorder Opportunity Expands; $94 Price Target Maintained
PremiumRatingsBuy Rating Reaffirmed on BioMarin as Voxzogo Skeletal Disorder Opportunity Expands; $94 Price Target Maintained
1M ago
BMRN
BioMarin’s Voxzogo meets endpoint in Phase 3 pediatric hypochondroplasia trial
Premium
The Fly
BioMarin’s Voxzogo meets endpoint in Phase 3 pediatric hypochondroplasia trial
1M ago
BMRN
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
Premium
The Fly
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
1M ago
AMT
BAP
BioMarin price target lowered to $80 from $85 at BofA
PremiumThe Fly
BioMarin price target lowered to $80 from $85 at BofA
1M ago
BMRN
BioMarin initiated with a Buy at Citi
PremiumThe Fly
BioMarin initiated with a Buy at Citi
1M ago
BMRN
BioMarin price target lowered to $62 from $64 at Leerink
PremiumThe Fly
BioMarin price target lowered to $62 from $64 at Leerink
1M ago
BMRN
BioMarin price target lowered to $50 from $55 at H.C. Wainwright
PremiumThe Fly
BioMarin price target lowered to $50 from $55 at H.C. Wainwright
1M ago
BMRN
BioMarin’s BMN 401 meets 1 of 2 endpoints in Phase 3 ENPP1 trial
PremiumThe FlyBioMarin’s BMN 401 meets 1 of 2 endpoints in Phase 3 ENPP1 trial
1M ago
BMRN
Dell downgraded, Uber upgraded: Wall Street’s top analyst calls
Premium
The Fly
Dell downgraded, Uber upgraded: Wall Street’s top analyst calls
2M ago
CG
FTV
BioMarin reinstated with a Neutral at Goldman Sachs
Premium
The Fly
BioMarin reinstated with a Neutral at Goldman Sachs
2M ago
BMRN
BioMarin price target raised to $116 from $104 at Canaccord
PremiumThe Fly
BioMarin price target raised to $116 from $104 at Canaccord
2M ago
BMRN
BioMarin price target lowered to $119 from $120 at Morgan Stanley
PremiumThe Fly
BioMarin price target lowered to $119 from $120 at Morgan Stanley
2M ago
BMRN
BioMarin price target raised to $120 from $110 at Evercore ISI
PremiumThe Fly
BioMarin price target raised to $120 from $110 at Evercore ISI
2M ago
BMRN
BioMarin price target lowered to $82 from $94 at Bernstein
PremiumThe Fly
BioMarin price target lowered to $82 from $94 at Bernstein
2M ago
BMRN
BioMarin: Buy Rating Reiterated on Amicus Acquisition Upside and Pipeline Catalysts; $85 Price Target Unchanged
PremiumRatingsBioMarin: Buy Rating Reiterated on Amicus Acquisition Upside and Pipeline Catalysts; $85 Price Target Unchanged
2M ago
BMRN
BioMarin Buy Rating Reiterated on Amicus Acquisition Synergies and Long-Term Upside; $120 Price Target Unchanged
Premium
Ratings
BioMarin Buy Rating Reiterated on Amicus Acquisition Synergies and Long-Term Upside; $120 Price Target Unchanged
2M ago
BMRN
BioMarin Boosts 2026 Outlook After Amicus Deal
Premium
Company Announcements
BioMarin Boosts 2026 Outlook After Amicus Deal
2M ago
BMRN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >